- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Structural Insights into Substrate Binding by <i>Pv</i> FKBP35, a Peptidylprolyl <i>cis-trans</i> Isomerase from the Human Malarial Parasite Plasmodium vivax
-
- Reema Alag
- School of Biological Sciences, Nanyang Technological University, Singapore
-
- Asha Manikkoth Balakrishna
- School of Biological Sciences, Nanyang Technological University, Singapore
-
- Sreekanth Rajan
- School of Biological Sciences, Nanyang Technological University, Singapore
-
- Insaf A. Qureshi
- School of Biological Sciences, Nanyang Technological University, Singapore
-
- Joon Shin
- School of Biological Sciences, Nanyang Technological University, Singapore
-
- Julien Lescar
- School of Biological Sciences, Nanyang Technological University, Singapore
-
- Gerhard Grüber
- School of Biological Sciences, Nanyang Technological University, Singapore
-
- Ho Sup Yoon
- School of Biological Sciences, Nanyang Technological University, Singapore
Search this article
Description
<jats:title>ABSTRACT</jats:title> <jats:p> The immunosuppressive drug FK506 binding proteins (FKBPs), an immunophilin family with the immunosuppressive drug FK506 binding property, exhibit peptidylprolyl <jats:italic>cis-trans</jats:italic> isomerase (PPIase) activity. While the cyclophilin-catalyzed peptidylprolyl isomerization of X-Pro peptide bonds has been extensively studied, the mechanism of the FKBP-mediated peptidylprolyl isomerization remains uncharacterized. Thus, to investigate the binding of FKBP with its substrate and the underlying catalytic mechanism of the FKBP-mediated proline isomerization, here we employed the FK506 binding domain (FKBD) of the human malarial parasite <jats:named-content content-type="genus-species">Plasmodium vivax</jats:named-content> FK506 binding protein 35 ( <jats:italic>Pv</jats:italic> FKBP35) and examined the details of the molecular interaction between the isomerase and a peptide substrate. The crystallographic structures of apo <jats:italic>Pv</jats:italic> FKBD35 and its complex with the tetrapeptide substrate succinyl-Ala-Leu-Pro-Phe- <jats:italic>p</jats:italic> -nitroanilide (sALPFp) determined at 1.4 Å and 1.65 Å resolutions, respectively, showed that the substrate binds to <jats:italic>Pv</jats:italic> FKBD35 in a <jats:italic>cis</jats:italic> conformation. Nuclear magnetic resonance (NMR) studies demonstrated the chemical shift perturbations of D55, H67, V73, and I74 residues upon the substrate binding. In addition, the X-ray crystal structure, along with the mutational studies, shows that Y100 is a key residue for the catalytic activity. Taken together, our results provide insights into the catalytic mechanism of <jats:italic>Pv</jats:italic> FKBP35-mediated <jats:italic>cis-trans</jats:italic> isomerization of substrate and ultimately might aid designing substrate mimetic inhibitors targeting the malarial parasite FKBPs. </jats:p>
Journal
-
- Eukaryotic Cell
-
Eukaryotic Cell 12 (4), 627-634, 2013-04
American Society for Microbiology
- Tweet
Details 詳細情報について
-
- CRID
- 1361137045588966016
-
- ISSN
- 15359786
- 15359778
-
- Data Source
-
- Crossref